Global Pharmaceutical Contract Manufacturing Market by Product (API, FDF, Advanced Drug Delivery, OTC Medicines & Nutritional), Application (Pharmaceutical, Biopharmaceutical), End User, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025
Published On: March 2019
 
Report ID:375968
 
Category: Pharmaceutical
 
Pages: N/A




Global pharmaceutical contract manufacturing market is expected to reach USD 150.82 billion by 2025, at a CAGR of 5.35% from 2018 to 2025. The increasing subcontracting volume by big pharmaceutical companies, expansion in the service offering of complementary metal–oxide–semiconductor (CMOS), and advent of contract development & manufacturing organization (CDMO) model into the market and growing investment in R&D are the major trends for the demand of the market.

Market Overview:

The demand for generic medicines and biologics, capital-intensive nature of the business, and complex manufacturing requirements are growing day-by-day. This has increased the focus of many pharmaceutical businesses to gain profitability in contracting with a CMO (contract manufacturing outsourcing). Pharmaceutical companies are relying on contract manufacturing and packaging services to meet their fundamental needs and specified competencies, along with accomplishing stringent regulations. For instance, Recipharm, a leading contract development, and manufacturing organization (CDMO) signed a contract with Kancera; a development company focused on cancer therapy for the development and manufacture of the pharmaceutical candidate, named as KAND567.

Report Description:

  • The base year for the study has been considered 2017, the historic year 2015 and 2016, the forecast period considered is from 2018 to 2025.
  • The study delivers a comprehensive analysis of the global pharmaceutical contract manufacturing market by product, application, end user, and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used to recognize the competitive scenario in the global pharmaceutical contract manufacturing market. This report incorporates the industry analysis which is focused on providing an extensive view of the Pharmaceutical Contract Manufacturing market.
  • The study also includes attractiveness analysis of product, application, end user, and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the pharmaceutical contract manufacturing market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • The increasing subcontracting volume by big pharmaceutical companies
  • Expansion in the service offering of complementary metal–oxide–semiconductor (CMOS)
  • Advent of contract development & manufacturing organization (CDMO) model into the market
  • Growing investment in R&D

Restraints:

  • Increasing lead time and logistics costs
  • Stringent regulatory requirements

Opportunities:

  • Increasing demand for next-generation biological therapies

Challenges:

  • Capacity utilization issues affecting the profitability of CMOS

Global Pharmaceutical Contract Manufacturing Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The pharmaceutical contract manufacturing market is segmented by product, application, and end user.

  • Product segment covers active pharmaceutical ingredients (API), finished dosage formulations (FDF), advanced drug delivery products, over the counter (OTC) medicines and nutritional products, and others. The finished dosage formulations segment is further divided into a tablet, capsule, oral liquids, parenteral/injectables, and others. Active pharmaceutical ingredients (API) segment held the highest market share of 27.14% in 2017 due to a strong surge in demand, especially in the generics sector.
  • Application segment pharmaceutical and biopharmaceutical.  The pharmaceutical segment valued around USD 53.13 Billion in 2017. The pharmaceutical companies gaining potential profitability in contracting with a CMO (contract manufacturing outsourcing) for both clinical and commercial stage manufacturing has increased the market for the pharmaceutical segment in this market.
  • End-user segment includes sterile and non-sterile. The sterile segment is anticipated to grow with the highest CAGR 7.01% during the forecast period owing to investments in R&D.

Regional Segmentation Analysis:

The market is analyzed by five regions namely North America, Europe, Asia Pacific, South America, and the Middle East and Africa. North America region held the largest market share of approximately 38.44% in 2017 where as the Asia Pacific region held the second dominant position in the global pharmaceutical contract manufacturing market

  • The increasing research activities by biotechnology companies and the rising demand for generics are some of the factors that led to the growth of pharmaceutical contract manufacturing market in the North America region.
  • In the Asia Pacific is the fastest growing region due to the improving healthcare infrastructure, an increasing number of companies are setting up manufacturing facilities in the emerging countries, and increasing favorable government initiatives.

Global Pharmaceutical Contract Manufacturing Market Competitive Analysis:

Key players in the pharmaceutical contract manufacturing market are Jubilant Life Sciences Ltd, Catalent Inc., Recipharm AB, Patheon Inc., Boehringer Ingelheim, Pfizer Centresource, Baxter Biopharma Solutions, Aenova, Famar, Lonza, Aesica Pharmaceuticals, Mylan, Vetter Pharma International, Fareva Group. The Patheon, Catalent, Lonza, Evonik Industries, Boehringer Ingelheim are the top leading players of the market. For instance, Catalent Inc. acquired Cook Pharmica LLC. This acquisition strengthened Catalent’s position in biologics development and analytical services and also complemented capabilities and expertise in biologic drug development programs.

 

This study forecasts revenue and volume growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global Pharmaceutical Contract Manufacturing market by below-mentioned segments:

Global Pharmaceutical Contract Manufacturing Market, By Product:

  • Active Pharmaceutical Ingredients (API)
  • Finished Dosage Formulations (FDF)
    • Tablet
    • Capsule
    • Oral Liquids
    • Parenteral/Injectables
    • Others
  • Advanced Drug Delivery Products
  • OTC Medicines and Nutritional Products
  • Others

Global Pharmaceutical Contract Manufacturing Market, By Application:

  • Pharmaceutical
  • Biopharmaceutical

Global Pharmaceutical Contract Manufacturing Market, By End User:

  • Sterile
  • Non-Sterile

Global Pharmaceutical Contract Manufacturing Market, By Regions:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Sweden
    • Netherlands
    • U.K.
    • Italy
    • Spain
    • Turkey
    • Switzerland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

1. Introduction
   1.1. Objectives of the Study
   1.2. Market Definition
   1.3. Research Scope
   1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
   4.1. Porter’s Five Forces Analysis
   4.2. Value Chain Analysis
   4.3. Top Investment Pockets
        4.3.1. Market Attractiveness Analysis By Product
        4.3.2. Market Attractiveness Analysis By Application
        4.3.3. Market Attractiveness Analysis By Organization Type
        4.3.4. Market Attractiveness Analysis By Industry
        4.3.5. Market Attractiveness Analysis By Region
   4.4. Industry Trends

5. Market Dynamics
   5.1. Market Evaluation
   5.2. Drivers
        5.2.1. The Increasing Subcontracting Volume By Big Pharmaceutical Companies
        5.2.2. Expansion In The Service Offering Of Complementary Metal–Oxide–Semiconductor (CMOS)
        5.2.3. Advent Of Contract Development & Manufacturing Organization (CDMO) Model Into The Market
        5.2.4. Growing Investment In R&D
   5.3. Restraints
        5.3.1. Increasing Lead Time And Logistics Costs
        5.3.2. Stringent Regulatory Requirements
   5.4. Opportunities
        5.4.1. Increasing Demand For Next-Generation Biological Therapies
   5.5. Challenges
        5.5.1. Capacity Utilization Issues Affecting The Profitability Of CMOS

6. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast, By Product
   6.1. Segment Overview
   6.2. Active Pharmaceutical Ingredients (API)
   6.3. Finished Dosage Formulations (FDF)
        6.3.1. Tablet
        6.3.2. Capsule
        6.3.3. Oral Liquids
        6.3.4. Parenteral/Injectables
        6.3.5. Others
   6.4. Advanced Drug Delivery Products
   6.5. OTC Medicines and Nutritional Products
   6.6. Others

7. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast, By Application
   7.1. Segment Overview
   7.2. Pharmaceutical
   7.3. Biopharmaceutical

8. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast, By End User
   8.1. Segment Overview
   8.2. Sterile
   8.3. Non-Sterile

9. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast, By Regional Analysis
   9.1. Segment Overview
   9.2. North America
        9.2.1. U.S.
        9.2.2. Canada
        9.2.3. Mexico
   9.3. Europe
        9.3.1. Germany
        9.3.2. France
        9.3.3. Sweden
        9.3.4. Netherlands
        9.3.5. U.K.
        9.3.6. Italy
        9.3.7. Spain
        9.3.8. Turkey
        9.3.9. Switzerland
        9.3.10. Belgium
        9.3.11. Rest of Europe
   9.4. Asia-Pacific
        9.4.1. Japan
        9.4.2. China
        9.4.3. India
        9.4.4. South Korea
        9.4.5. Australia
        9.4.6. Singapore
        9.4.7. Malaysia
        9.4.8. Thailand
        9.4.9. Indonesia
        9.4.10. Philippines
        9.4.11. Rest of Asia-Pacific
   9.5. South America
        9.5.1. Brazil
        9.5.2. Argentina
        9.5.3. Colombia
        9.5.4. Rest of South America
   9.6. Middle East and Africa
        9.6.1. Saudi Arabia
        9.6.2. UAE
        9.6.3. Egypt
        9.6.4. Nigeria
        9.6.5. South Africa
        9.6.6. Rest of  Middle East and Africa

10. Global Pharmaceutical Contract Manufacturing Market-Competitive Landscape
   10.1. Overview
   10.2. Market Share of Key Players in the Pharmaceutical Contract Manufacturing Market
        10.2.1. Global Company Market Share
        10.2.2. North America Company Market Share
        10.2.3. Europe Company Market Share
        10.2.4. APAC Company Market Share
   10.3. Competitive Situations and Trends
        10.3.1. Application Launches and Developments
        10.3.2. Partnerships, Collaborations, and Agreements
        10.3.3. Mergers & Acquisitions
        10.3.4. Expansions

11. Company Profiles
   11.1. Jubilant Life Sciences Ltd
        11.1.1. Business Overview
        11.1.2. Company Snapshot
        11.1.3. Company Market Share Analysis
        11.1.4. Company Application Portfolio
        11.1.5. Recent Developments
        11.1.6. SWOT Analysis
   11.2. Catalent Inc.
        11.2.1. Business Overview
        11.2.2. Company Snapshot
        11.2.3. Company Market Share Analysis
        11.2.4. Company Application Portfolio
        11.2.5. Recent Developments
        11.2.6. SWOT Analysis
   11.3. Recipharm AB
        11.3.1. Business Overview
        11.3.2. Company Snapshot
        11.3.3. Company Market Share Analysis
        11.3.4. Company Application Portfolio
        11.3.5. Recent Developments
        11.3.6. SWOT Analysis
   11.4. Patheon Inc.
        11.4.1. Business Overview
        11.4.2. Company Snapshot
        11.4.3. Company Market Share Analysis
        11.4.4. Company Application Portfolio
        11.4.5. Recent Developments
        11.4.6. SWOT Analysis
   11.5. Boehringer Ingelheim
        11.5.1. Business Overview
        11.5.2. Company Snapshot
        11.5.3. Company Market Share Analysis
        11.5.4. Company Application Portfolio
        11.5.5. Recent Developments
        11.5.6. SWOT Analysis
   11.6. Pfizer Centresource
        11.6.1. Business Overview
        11.6.2. Company Snapshot
        11.6.3. Company Market Share Analysis
        11.6.4. Company Application Portfolio
        11.6.5. Recent Developments
        11.6.6. SWOT Analysis
   11.7. Baxter Biopharma Solutions
        11.7.1. Business Overview
        11.7.2. Company Snapshot
        11.7.3. Company Market Share Analysis
        11.7.4. Company Application Portfolio
        11.7.5. Recent Developments
        11.7.6. SWOT Analysis
   11.8. Aenova
        11.8.1. Business Overview
        11.8.2. Company Snapshot
        11.8.3. Company Market Share Analysis
        11.8.4. Company Application Portfolio
        11.8.5. Recent Developments
        11.8.6. SWOT Analysis
   11.9. Famar
        11.9.1. Business Overview
        11.9.2. Company Snapshot
        11.9.3. Company Market Share Analysis
        11.9.4. Company Application Portfolio
        11.9.5. Recent Developments
        11.9.6. SWOT Analysis
   11.10. Lonza
        11.10.1. Business Overview
        11.10.2. Company Snapshot
        11.10.3. Company Market Share Analysis
        11.10.4. Company Application Portfolio
        11.10.5. Recent Developments
        11.10.6. SWOT Analysis
   11.11. Aesica Pharmaceuticals
        11.11.1. Business Overview
        11.11.2. Company Snapshot
        11.11.3. Company Market Share Analysis
        11.11.4. Company Application Portfolio
        11.11.5. Recent Developments
        11.11.6. SWOT Analysis
   11.12. Mylan
        11.12.1. Business Overview
        11.12.2. Company Snapshot
        11.12.3. Company Market Share Analysis
        11.12.4. Company Application Portfolio
        11.12.5. Recent Developments
        11.12.6. SWOT Analysis
   11.13. Vetter Pharma International
        11.13.1. Business Overview
        11.13.2. Company Snapshot
        11.13.3. Company Market Share Analysis
        11.13.4. Company Application Portfolio
        11.13.5. Recent Developments
        11.13.6. SWOT Analysis
   11.14. Fareva Group
        11.14.1. Business Overview
        11.14.2. Company Snapshot
        11.14.3. Company Market Share Analysis
        11.14.4. Company Application Portfolio
        11.14.5. Recent Developments
        11.14.6. SWOT Analysis


List of Table
1. Global Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
2. Global Active Pharmaceutical Ingredients (API) Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion) 
3. Global Pharmaceutical Contract Manufacturing Market, By Finished Dosage Formulations (FDF), 2015–2025 (USD Billion) 
4. Global Tablet Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion) 
5. Global Capsule Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion) 
6. Global Oral Liquids Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion) 
7. Global Parenteral/Injectables Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion) 
8. Global Advanced Drug Delivery Products Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion) 
9. Global OTC Medicines and Nutritional Products Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion) 
10. Global Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
11. Global Pharmaceutical Pharmaceutical Contract Manufacturing Market, by Region, 2015–2025 (USD Billion) 
12. Global Biopharmaceutical Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion)
13. Global Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
14. Global Sterile Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion)
15. Global Non-Sterile Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion)
16. Global Pharmaceutical Contract Manufacturing Market, By Region, 2015–2025 (USD Billion) 
17. Global Pharmaceutical Contract Manufacturing Market, By North America, 2015–2025 (USD Billion) 
18. North America Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
19. North America Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
20. North America Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
21. U.S. Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
22. U.S. Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
23. U.S. Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
24. Canada Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
25. Canada Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
26. Canada Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
27. Mexico Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
28. Mexico Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
29. Mexico Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
30. Europe Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
31. Europe Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
32. Europe Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
33. Germany Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
34. Germany Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
35. Germany Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
36. France Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
37. France Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
38. France Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
39. Sweden Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
40. Sweden Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
41. Sweden Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
42. Netherlands Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
43. Netherlands Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
44. Netherlands Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
45. U.K. Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
46. U.K. Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
47. U.K. Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
48. Italy Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
49. Italy Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
50. Italy Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
51. Spain Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
52. Spain Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
53. Spain Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
54. Turkey Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
55. Turkey Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
56. Turkey Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
57. Switzerland Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
58. Switzerland Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
59. Switzerland Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
60. Belgium Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
61. Belgium Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
62. Belgium Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
63. Asia Pacific Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
64. Asia Pacific Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
65. Asia Pacific Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
66. Japan Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
67. Japan Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
68. Japan Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
69. China Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
70. China Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
71. China Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
72. India Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
73. India Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
74. India Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
75. South Korea Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
76. South Korea Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
77. South Korea Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
78. Australia Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
79. Australia Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
80. Australia Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
81. Singapore Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
82. Singapore Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
83. Singapore Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
84. Malaysia Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
85. Malaysia Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
86. Malaysia Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
87. Thailand Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
88. Thailand Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
89. Thailand Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
90. Indonesia Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
91. Indonesia Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
92. Indonesia Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
93. Philippines Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
94. Philippines Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
95. Philippines Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
96. South America Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
97. South America Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
98. South America Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
99. Brazil Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
100. Brazil Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
101. Brazil Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
102. Argentina Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
103. Argentina Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
104. Argentina Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
105. Colombia Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
106. Colombia Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
107. Colombia Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
108. Middle East and Africa Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
109. Middle East and Africa Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
110. Middle East and Africa Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
111. Saudi Arabia Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
112. Saudi Arabia Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
113. Saudi Arabia Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
114. UAE Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
115. UAE Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
116. UAE Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
117. Egypt Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
118. Egypt Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
119. Egypt Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
120. Nigeria Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
121. Nigeria Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
122. Nigeria Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 
123. South Africa Pharmaceutical Contract Manufacturing Market, By Product, 2015–2025 (USD Billion) 
124. South Africa Pharmaceutical Contract Manufacturing Market, By Application, 2015–2025 (USD Billion) 
125. South Africa Pharmaceutical Contract Manufacturing Market, By End User, 2015–2025 (USD Billion) 

List of Figures 
1. Global Pharmaceutical Contract Manufacturing Market Segmentation
2. Pharmaceutical Contract Manufacturing Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis 
7. Value Chain Analysis 
8. Global Pharmaceutical Contract Manufacturing Market Attractiveness Analysis By Product
9. Global Pharmaceutical Contract Manufacturing Market Attractiveness Analysis By Application
10. Global Pharmaceutical Contract Manufacturing Market Attractiveness Analysis By End User
11. Global Pharmaceutical Contract Manufacturing Market Attractiveness Analysis By Region
12. Global Pharmaceutical Contract Manufacturing Machine Market: Dynamics
13. Global Pharmaceutical Contract Manufacturing Machine Market Share By Products (2017 & 2025)
14. Global Pharmaceutical Contract Manufacturing Machine Market Share By Application (2017 & 2025)
15. Global Pharmaceutical Contract Manufacturing Machine Market Share By End User (2017 & 2025)
16. Global Pharmaceutical Contract Manufacturing Machine Market Share By Region (2017 & 2025)
17. Global Pharmaceutical Contract Manufacturing Machine Market Share By Company (2018)



Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.